Bisoprolol ‘safe’ in COPD patients: study


RCT results show the cardio-selective beta-blocker is no longer contraindicated in this patient population, says lead Bisoprolol can be safely used in people with chronic obstructive pulmonary disease (COPD), according to the findings of a new Australia-led randomised controlled trial. Results from the double-blind RCT across 22 sites conducted over two years showed no significant

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous The top 10 of the last 10 years
Next World news wrapup: 29 January 2026